Apollo Hospitals Enterprise is currently trading at Rs. 3910.00, up by 27.60 points or 0.71% from its previous closing of Rs. 3882.40 on the BSE.
The scrip opened at Rs. 3932.30 and has touched a high and low of Rs. 3932.30 and Rs. 3890.30 respectively. So far 7278 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 5930.70 on 26-Nov-2021 and a 52 week low of Rs. 3365.90 on 26-May-2022.
Last one week high and low of the scrip stood at Rs. 3932.30 and Rs. 3638.85 respectively. The current market cap of the company is Rs. 56219.80 crore.
The promoters holding in the company stood at 29.33%, while Institutions and Non-Institutions held 64.35% and 6.32% respectively.
Apollo Hospitals Enterprise has collaborated with Singapore-based ConnectedLife to integrate its cardiovascular risk assessment tool with the latter’s digital wellness solutions. Under the partnership, Apollo’s AICVD tool which can predict the risk of cardiovascular disease will be integrated with ConnectedLife’s digital solutions for wellness, condition management and other health-focused applications.
This will empower healthcare providers with the tools to predict the risk of cardiac disease in their patients and initiate intervention early enough to make a real difference.
Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.